REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS DR. SULLIVAN S MONOGRAPH

Size: px
Start display at page:

Download "REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS DR. SULLIVAN S MONOGRAPH"

Transcription

1 REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS DR. SULLIVAN S MONOGRAPH

2 REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS ACTIVITY DESCRIPTION This program will assist pharmacy technicians to understand the federal laws applicable to pharmacy. Topics covered include package inserts, dispensing controlled substances and schedule II controlled substances. The information in the monograph is based on the Federal Law and the Federal Controlled Substance Act. Some of the information may be different in different states. States can make their own laws more restrictive than federal law, but not less restrictive. All questions regarding the practice of pharmacy should be directed to a pharmacist or the Board of the Pharmacy in the state where the technician works. TARGET AUDIENCE The target audience for this activity is pharmacy technicians in hospital, community, and retail pharmacy settings. LEARNING OBJECTIVES After completing this activity, the pharmacy technicians will be able to: Identify when it is appropriate to provide Patient Package Inserts Describe common legal issues when dispensing controlled substances Identify the legal requirements specific to schedule II controlled substances ACCREDITATION PHARMACY PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. NURSING PharmCon, Inc. is approved by the California Board of Registered Nursing (Provider Number CEP 13649) and the Florida Board of Nursing (Provider Number ). Activities approved by the CA BRN and the FL BN are accepted by most State Boards of Nursing. CE hours provided by PharmCon, Inc. meet the ANCC criteria for formally approved continuing education hours. The ACPE is listed by the AANP as an acceptable, accredited continuing education organization for applicants seeking renewal through continuing education credit. For additional information, please visit Universal Activity No.: H03-T Credits: 1 contact hour (0.1 CEU) Release Date: February 14, 2013 Expiration Date: February 14, 2016 ACTIVITY TYPE Knowledge-Based Home Study Monograph FINANCIAL SUPPORT BY Pharmaceutical Education Consultants, Inc. 1

3 ABOUT THE AUTHOR Donnie Sullivan is a Professor of Clinical Pharmacy and Director of Experimental Education at The Ohio State University. He received his B.S. in pharmacy from Ohio State University in 1990, his MS from Ohio State University in 1991, and his Ph.D. is Pharmacy Administration from Ohio State University in He has published several peer-reviewed articles and five consumer drug reference books. He has taught courses in pharmacy law, medication error prevention, and OTC products for 15 years. He has done more than 90 professional presentations on pharmacy law, medication error prevention techniques, and OTC products all across the U.S. He has been voted professor of the year by his students in 13 of his 14 years at Ohio Northern University. Donald Sullivan, Ph.D. Professor of Clinical Pharmacy and Director of Experimental Education, Ohio State University FACULTY DISCLOSURE It is the policy of PharmCon, Inc. to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) and/or service(s) discussed in an educational activity. Donald Sullivan reports no actual or potential conflict of interest in relation to this activity. Peer review of the material in this CE activity was conducted to assess and resolve potential conflict of interest. Reviewers unanimously found that the activity is fair balanced and lacks commercial bias. Please Note: PharmCon, Inc. does not view the existence of relationships as an implication of bias or that the value of the material is decreased. The content of the activity was planned to be balanced and objective. Occasionally, authors may express opinions that represent their own viewpoint. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient or pharmacy management. Conclusions drawn by participants should be derived from objective analysis of scientific data presented from this monograph and other unrelated sources. 2

4 The information provided below is based on the Federal Law and the Federal Controlled Substance Act. Some of the information may be different in different states. States can make their own laws more restrictive than federal law, but not less restrictive. For example: As of the beginning of 2013, tramadol is not a controlled substance under federal law. However, some states have made it a schedule IV controlled substance (Kentucky is one example). Technicians should always check with their pharmacist regarding your own state s individual rules and laws regarding controlled substances when issues or questions arise regarding the practice of pharmacy. This program is for educational purposes. All questions regarding the practice of pharmacy should be directed to a pharmacist or the Board of the Pharmacy in the state where the technician works. Patient Package Inserts 1,2 The requirement of pharmacies to provide patient package inserts (PPIs) has been around for several years. The requirements for providing PPIs are for estrogen drug products including estrogen containing oral contraceptives. PPIs are also required for progesterone containing oral contraceptives as well. Pharmacies are required to provide a PPI for each package dispensed. The means that a PPI must be provided with each new and refill prescription dispensed for products in the above mentioned classes. Manufacturers are required to provide PPIs for pharmacies to dispense to patients with these prescriptions. If a pharmacy does not provide a PPI with an oral contraceptive, the product is considered to be misbranded and the pharmacy is in violation of federal law. Many pharmacies think that PPIs are not required for inpatients (hospital patients) and nursing home patients. This is not true. Federal law states that PPIs must be provided to the patient with the first dose of one of these medications and every 30 days thereafter. As a technician, if you are not sure if a PPI should be given to a patient or not, consult your pharmacist for direction. Common Legal Issues When Dispensing Controlled Substances 3,4 Let s discuss a couple of common situations that can occur when pharmacists are dispensing prescriptions for schedule II drugs. What should a pharmacist do if they do not have 3

5 enough medication in stock to fill a prescription for a schedule II drug? For example: The patient presents a prescription for Percocet 2.5/325 tablets #90 and the pharmacy only has 45 tablets in stock. In this situation, the pharmacy has 72 hours to dispense the remaining quantity (in this example 45 tablets). The pharmacy must order and obtain the remaining 45 tablets and dispense them within 72 hours. The pharmacist should also document on the front of the prescription the quantity (45 tablets) dispensed. If the pharmacy cannot dispense the remaining 45 tablets within 72 hours, the pharmacist must notify the prescribing practitioner. After 72 hours, no further medication can be dispensed from this original prescription. The patient may have to obtain a new prescription from the prescriber. In another related situation, what if the patient presents a prescription for Percocet 2.5/325 tablets #60 and can only afford 30 tablets at this specific time? In this situation, the patient can only receive what they can afford at the time of dispensing. The pharmacist cannot dispense the remaining quantity (30 tablets) at any time in the future. The 72 hour rule only applies to situations when the pharmacy does not have enough medication in stock. It does not apply to the situation when the patient cannot afford the entire quantity at the time of dispensing. What about for schedule III and IV controlled substances? Consider this example: A patient brings you a prescription for Vicodin, one tablet QID, prn #100 with 4 refills. The patient does not have health insurance and must pay cash for their prescriptions. The patient only wants to get 50 tablets at a time. How many times can the pharmacist fill this prescription with a quantity of 50? This is a point of confusion for many pharmacists. Vicodin is a schedule III controlled substance. Every pharmacist knows the maximum number of refills on a schedule III controlled substance is 5 refills or 6 months. However, does that mean this patient can only receive 5 refills of 50? Under federal law, the answer to that question is no. In this situation, this is a considered a partial refill. The total quantity on the prescription, including refills, is 500 tablets. The patient is entitled to the entire quantity prescribed, even if this means the number of partial fillings exceeds five. However, the total quantity dispensed in all partial fillings cannot exceed the total quantity prescribed and all partial fills must be dispensed within 6 months of the date the prescription was written. Theoretically, the patient could receive 9 partial refills (the original 50 tablets plus nine partial refills of 50 tablets) within a 6 month 4

6 period. Pharmacists should also realize that each partial filling is recorded in the same manner as a refill. Finally, the six month time period for all the partial fills begins from the date the prescription was written and not the date of first dispensing. Requirements for Faxing a Schedule II Prescription 3,5 In general, pharmacists can receive prescriptions via a facsimile (fax) machine for all prescription drugs except schedule II controlled substances. However, there are three exceptions when pharmacies can receive a faxed prescription for a schedule II controlled substance. 1) A pharmacy can receive a faxed schedule II prescription for a narcotic substance for any patient in hospice care. The prescriber must note on the prescription that it is for a hospice patient. 2) A pharmacy can receive a faxed schedule II prescription for patients in long-term care facilities or nursing homes. This does not include assisted living facilities. 3) A pharmacy can receive a faxed schedule II prescription for a narcotic substance for any patient undergoing home infusion/intravenous (IV) pain therapy. In all three of the above circumstances, the faxed prescription is considered to be the original prescription and should be processed and filed accordingly. The prescriber does not have to send the original prescription to the pharmacy. In other instances (other than the three discussed above), a physician may want to fax a schedule II controlled substance prescription to the pharmacy so the pharmacist can have it ready when the patient arrives. It is important to know that the pharmacist cannot dispense the medication until the patient brings the original, hard copy prescription from the physician, and the pharmacist should verify it against the faxed copy. The hard copy, written prescription is considered the original prescription and should be filed accordingly. Requirements for Oral Schedule II Prescriptions 3,7 In some rare circumstance, a prescriber may need to call in an oral prescription for schedule II drug for a patient. Even though this is a very infrequent situation, pharmacists should know the legal requirements. First, many pharmacists think that they can only dispense 5

7 no more than a 72 hour supply of a schedule II drug on an oral prescription. This is not true. The amount a pharmacist can dispense is defined as enough for the emergency period. In these situations, the pharmacist and prescriber must discuss the patient s situation and use their collective professional judgment. In certain cases only a 24 hour supply may be necessary, but in other cases more than a 72 hour supply may be necessary. The pharmacist should document this conversation with the prescriber. Requirements of a pharmacist regarding an oral schedule II prescription are as follows: 1) The quantity prescribed and dispensed should be enough for only the emergency period. 2) The pharmacist should immediately reduce the oral prescription to writing and it must contain all of the information required for a written prescription for a controlled substance. 3) The pharmacist must receive the written prescription from the prescriber within 7 days. This written prescription must be attached to the oral prescription taken by the pharmacist. On this written prescription must be the statement Authorization for Emergency Dispensing. The written prescription may be delivered in person or by mail with the postmark on the envelope within the seven day period. Once software systems are approved by the DEA, an electronic prescription may be sent by the physician to the pharmacy in lieu of a written prescription. 4) If the physician does not provide the written prescription within seven days, the pharmacist should notify the local DEA office. Requirements for Partially Dispensing Schedule II Controlled Substances 3,8 A caregiver for a terminally ill patient comes into your pharmacy. The patient received a prescription from his doctor for Percocet 5/325, #120, one tablet 6 hours. The caregiver tells the pharmacist that the patient has taken a turn for the worse and may only live 72 hours. The caregiver wants to know, Do I have to get the entire 120 tablets filled? The answer in this specific case is No. There are two situations in which pharmacists can partially dispense a schedule II controlled substance: 1) for terminally ill patients and 2) for patients in a long-term care facility. This does not include assisted living facilities. In the above situation, the pharmacist could dispense twelve Percocet 5/325 tablets and the patient would have 108 tablets remaining to be dispensed. However, if a pharmacist is going to partially dispense a schedule II prescription to either a terminally ill or hospice patient, there are some regulations he/she must follow. 6

8 Before partially dispensing a schedule II controlled substance, the pharmacist must confirm that the patient is either terminally ill or resides in a long-term care facility. This must be written on the prescription. The partial dispensing can only occur at the pharmacy where the original prescription is on file. In pharmacies that utilize a shared database, partial dispensing can only occur at the specific location where the original prescription was first filled. Also, the total quantity dispensed through all partial fills cannot exceed the total quantity on the written prescription. Partial dispensing of the prescription can occur for 60 days from the date the prescription was written, not the date of the first partial dispensing. The 60-day timeclock starts with the date on the prescription. Any quantity left-over after 60 days cannot be partially dispensed. At the time of each partial dispensing, the following information must be recorded on the back of the original prescription: a) date dispensed b) quantity dispensed c) remaining quantity d) The new prescription number of each partial dispensing if it is different from the original prescription number. e) Written initials of the dispensing pharmacist If the computer system does not permit refilling of a schedule II controlled substance, a new prescription number for the partial dispensing must be assigned. In the computer database, a notation must be included that identifies this new prescription number as a partial dispensing. A prescription bearing the new prescription number must be placed in the schedule II file. The prescription for each partial filling must also show the prescription number for the original. Multiple Prescriptions for Schedule II Drugs 9,10 Let s consider this example. A parent takes their child to visit their physician for a follow-up visit regarding their ADHD on September 1 st, The child has been taking Adderall XR 10mg, #60, once daily in the morning for 18 months. The parent has seen a 7

9 dramatic improvement in the child s behavior at home and school. The last visit to the physician was on July 15 th, 2012 when the parent received a prescription for the same 60 daysupply of drug. The physician knows the patient has enough medication until September 14 th, He does not want the parent to have the prescription filled until that date. What should the physician do? The physician may be tempted to post-date the prescription with the date September 14 th, This is illegal. Prescriptions must be dated on the day that the physician signs and issues the prescription. Therefore the date on the prescription must be September 1 st, Post-dated prescriptions are illegal. The best option for the physician is to write in the directions of the prescription, Do not fill until September 14 th, A change in federal law allowing physicians to do this and issue multiple prescriptions for schedule II drugs became effective on December 19, This law allows physicians to issue multiple prescriptions for a schedule II drug with do not fill until on them for up to a 90 day supply of medication. Let s consider another example. A physician decides that he/she only needs to see a child every 90 days for his ADHD. The date of the physician visit is October 1, The physician could write three prescriptions on October 1, 2012 for Adderall XR 5mg, #30, one daily. The first prescription would have nothing additional in the directions. The second prescription would have Do not fill until October 31, 2012 in the directions, and the third would have Do not fill until December 1, All three of these prescriptions would have the date issued as October 1, With these dates on the prescriptions, pharmacists are prohibited from filling them before these dates. Also, the physician is not required to write these prescriptions in 30 day increments. Another physician may want to issue six prescriptions for a 14 day supply on each with the appropriate do not fill until dates on each one. In summary, the total days supply when multiple prescriptions are issued for a schedule II drug with do not fill until on it is 90 days. Example: What if the physician does not want to issue three separate prescriptions with do not fill dates on them and wants to write just one prescription for Adderall XR 5mg, #90, one daily? Is this legal? The answer is Yes as long as it is for a legitimate medical purpose. However, some states may have laws that limit the quantity and/or days supply on a prescription for a schedule II drug, so be careful. Finally, this law does not require physicians to see their patients every 90 days. The length of time between appointments and care that 8

10 needs to be given is left up to the discretion of the physician. In some cases, patients who are very stable on their therapy may need to be seen only two or three times a year. References CFR CFR Leonhard, Michele, Rannazzisi, Joseph, and Caverly, Mark. Pharmacists Manual. Drug Enforcement Administration, Washington. DC CFR CFR CFR CFR (d) CFR CFR CFR

11 ACTIVITY TEST 1. Patient package inserts must be given with both new and refill prescriptions for oral contraceptives. A. True B. False 2. A prescription is brought to the pharmacy for Dilaudid 1mg tablets (schedule II), #50. The pharmacy only has 25 tablets in stock. How long does the pharmacy have to dispense the remaining 25 tablets? A. 24 hours B. 48 hours C. 72 hours D. 30 days E. 45 days 3. A patient comes to the pharmacy with a prescription for oxycodone 5mg tablets (schedule II) #50. The patient wants to get 25 tablets filled today and 25 tablets filled in two weeks. Can the pharmacist fill the remaining 25 tablets in two weeks? A. Yes B. No 4. A patient brings a prescription for Vicodin (schedule III) #100 tablets. The patient only wants to get 10 tablets filled at a time. How long does the patient have to get the remaining 90 tablets filled? A. 24 hours B. 48 hours C. 7 days D. 6 months E. None. The entire 100 must be filled at the same time. 5. A physician wants to call in an oral prescription for Dilaudid 2mg (schedule II) for a patient who is homebound with terminal cancer. What is the maximum amount the physician can prescribe on an oral prescription for a schedule II drug? A. 1 day supply B. 2 day supply C. 3 day supply D. enough for the emergency period 10

12 6. If a physician calls in an emergency oral prescription for a schedule II narcotic (Percocet 5/325 ), he/she has to get the written original prescription to the pharmacy. A. 24 hours B. 48 hours C. 7 days D. 10 days E. 30 days 7. Physicians may fax a schedule II prescription to the pharmacy under which of the following circumstances: A. A narcotic pain killer for a hospice patient B. For a patient in a nursing home or long-term care facility C. For a patient undergoing narcotic home infusion (IV) pain therapy D. a and c only E. a, b, and c 8. Pharmacists can partially dispense schedule II controlled substances for which of the following patients? A. nursing home patients B. patients who are terminally ill C. A patient who wants to try just 2 tablets to make sure they work before buying the rest D. a and b only E. all of the above 9. Partial dispensing of a schedule II controlled substance can occur for from the date the prescription was written. A. 10 days B. 30 days C. 60 days D. 6 months 10. A physician can write Do Not Fill Until on one or more schedule II prescriptions for up to A. 30 days B. 60 days C. 90 days D. 6 months E. This cannot be done under any circumstances. Please submit your final responses on freece.com. Thank you. 11

A REVIEW OF FEDERAL PHARMACY LAW DONALD SULLIVAN, PH.D

A REVIEW OF FEDERAL PHARMACY LAW DONALD SULLIVAN, PH.D A REVIEW OF FEDERAL PHARMACY LAW DONALD SULLIVAN, PH.D A REVIEW OF FEDERAL PHARMACY LAW ACTIVITY DESCRIPTION This program will discuss the federal legal requirements for dispensing controlled substances

More information

PREVENTING MEDICATION ERRORS IN PHARMACY PRACTICE DR. SULLIVAN S SUPPLEMENTAL HANDOUT

PREVENTING MEDICATION ERRORS IN PHARMACY PRACTICE DR. SULLIVAN S SUPPLEMENTAL HANDOUT PREVENTING MEDICATION ERRORS IN PHARMACY PRACTICE DR. SULLIVAN S SUPPLEMENTAL HANDOUT PREVENTING MEDICATION ERRORS IN PHARMACY PRACTICE ACTIVITY DESCRIPTION Medications errors may occur more often than

More information

OVERVIEW OF RECENT PHARMACY LAW CASES DAVID BRUSHWOOD, JD, RPH

OVERVIEW OF RECENT PHARMACY LAW CASES DAVID BRUSHWOOD, JD, RPH OVERVIEW OF RECENT PHARMACY LAW CASES DAVID BRUSHWOOD, JD, RPH OVERVIEW OR RECENT PHARMACY LAW CASES ACTIVITY DESCRIPTION This class reviews six legal cases in which allegations were made that pharmacy

More information

BE WISE, IMMUNIZE: AN UPDATE ON IMMUNIZATION PRACTICES GRETCHEN KRECKEL GAROFOLI, PHARMD

BE WISE, IMMUNIZE: AN UPDATE ON IMMUNIZATION PRACTICES GRETCHEN KRECKEL GAROFOLI, PHARMD BE WISE, IMMUNIZE: AN UPDATE ON IMMUNIZATION PRACTICES GRETCHEN KRECKEL GAROFOLI, PHARMD BE WISE, IMMUNIZE: AN UPDATE ON IMMUNIZATION PRACTICES ACTIVITY DESCRIPTION With over 230,000 pharmacists trained

More information

PRS 101 FOUNDATIONS OF PHARMACY REGULATION PRS 101.3: THE DRUG ENFORCEMENT ADMINISTRATION REGULATORY ROLE DR. BRUSHWOOD S MONOGRAPH

PRS 101 FOUNDATIONS OF PHARMACY REGULATION PRS 101.3: THE DRUG ENFORCEMENT ADMINISTRATION REGULATORY ROLE DR. BRUSHWOOD S MONOGRAPH PRS 101 FOUNDATIONS OF PHARMACY REGULATION PRS 101.3: THE DRUG ENFORCEMENT ADMINISTRATION REGULATORY ROLE DR. BRUSHWOOD S MONOGRAPH PRS 101.3 THE DRUG ENFORCEMENT ADMINISTRATION REGULATORY ROLE ACTIVITY

More information

DEFENDING A FEDERAL CRIMINAL CHARGE AND A BOARD ACTION ROBERT ESGRO, RPH, ESQ

DEFENDING A FEDERAL CRIMINAL CHARGE AND A BOARD ACTION ROBERT ESGRO, RPH, ESQ DEFENDING A FEDERAL CRIMINAL CHARGE AND A BOARD ACTION ROBERT ESGRO, RPH, ESQ DEFENDING A FEDERAL CRIMINAL CHARGE AND A BOARD ACTION ACTIVITY DESCRIPTION Generally, medical malpractice is litigated as

More information

PRS 103 CONTEMPORARY ISSUES IN PHARMACY REGULATION PRS 103.6: LICENSURE AS ASSURANCE OF COMPETENCE DR. BRUSHWOOD S MONOGRAPH

PRS 103 CONTEMPORARY ISSUES IN PHARMACY REGULATION PRS 103.6: LICENSURE AS ASSURANCE OF COMPETENCE DR. BRUSHWOOD S MONOGRAPH PRS 103 CONTEMPORARY ISSUES IN PHARMACY REGULATION PRS 103.6: LICENSURE AS ASSURANCE OF COMPETENCE DR. BRUSHWOOD S MONOGRAPH PRS 103.6: LICENSURE AS ASSURANCE OF COMPETENCE ACTIVITY DESCRIPTION This monograph

More information

WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES MARK GAROFOLI, PHARMD, MBA, CGP PETE KRECKEL, RPH

WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES MARK GAROFOLI, PHARMD, MBA, CGP PETE KRECKEL, RPH WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES MARK GAROFOLI, PHARMD, MBA, CGP PETE KRECKEL, RPH WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES ACTIVITY DESCRIPTION

More information

RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD

RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE ACTIVITY DESCRIPTION Rheumatoid arthritis (RA) is an inflammatory type of

More information

A FOCUS ON TOPICS IN OHIO PHARMACY LAW -- OHIO STATE BOARD OF PHARMACY APPROVED DR. SULLIVAN S MONOGRAPH

A FOCUS ON TOPICS IN OHIO PHARMACY LAW -- OHIO STATE BOARD OF PHARMACY APPROVED DR. SULLIVAN S MONOGRAPH A FOCUS ON TOPICS IN OHIO PHARMACY LAW -- OHIO STATE BOARD OF PHARMACY APPROVED DR. SULLIVAN S MONOGRAPH A FOCUS ON TOPICS IN OHIO PHARMACY LAW -- OHIO STATE BOARD OF PHARMACY APPROVED ACTIVITY DESCRIPTION

More information

ON PENS AND NEEDLES A PRIMER ON INSULIN PENS AND PROPER INJECTION TECHNIQUES PETE KRECKEL, RPH

ON PENS AND NEEDLES A PRIMER ON INSULIN PENS AND PROPER INJECTION TECHNIQUES PETE KRECKEL, RPH ON PENS AND NEEDLES A PRIMER ON INSULIN PENS AND PROPER INJECTION TECHNIQUES PETE KRECKEL, RPH ON PENS AND NEEDLES - A PRIMER ON INSULIN PENS AND PROPER INJECTION TECHNIQUES ACTIVITY DESCRIPTION Insulin

More information

MOVEMENT BEYOND LAXATIVES: EVOLVING PHARMACOLOGIC OPTIONS FOR IBS-C AND CIC PETE KRECKEL, RPH

MOVEMENT BEYOND LAXATIVES: EVOLVING PHARMACOLOGIC OPTIONS FOR IBS-C AND CIC PETE KRECKEL, RPH MOVEMENT BEYOND LAXATIVES: EVOLVING PHARMACOLOGIC OPTIONS FOR IBS-C AND CIC PETE KRECKEL, RPH MOVEMENT BEYOND LAXATIVES: EVOLVING PHARMACOLOGIC OPTIONS FOR IBS-C AND CIC ACTIVITY DESCRIPTION IBS-C and

More information

SHOULD WE ALL TAKE OMEGA-3 FATTY ACID SUPPLEMENTS? GENEVA BRIGGS, PHARMD, BCPS

SHOULD WE ALL TAKE OMEGA-3 FATTY ACID SUPPLEMENTS? GENEVA BRIGGS, PHARMD, BCPS SHOULD WE ALL TAKE OMEGA-3 FATTY ACID SUPPLEMENTS? GENEVA BRIGGS, PHARMD, BCPS SHOULD WE ALL TAKE OMEGA-3 FATTY ACID SUPPLEMENTS? ACTIVITY DESCRIPTION The benefits of increasing intake of omega-3 fatty

More information

TESTOSTERONE REPLACEMENT THERAPY FOR THE AGING MALE: COUNSELING INSIGHTS FOR THE PHARMACIST TIM DRAKE, PHARM.D.

TESTOSTERONE REPLACEMENT THERAPY FOR THE AGING MALE: COUNSELING INSIGHTS FOR THE PHARMACIST TIM DRAKE, PHARM.D. TESTOSTERONE REPLACEMENT THERAPY FOR THE AGING MALE: COUNSELING INSIGHTS FOR THE PHARMACIST TIM DRAKE, PHARM.D. TESTOSTERONE REPLACEMENT THERAPY FOR THE AGING MALE: COUNSELING INSIGHTS FOR THE PHARMACIST

More information

MEMBER S CHOICE: THE REQUESTED SPANISH PHRASES FOR THE PHARMACY STEPHANIE LANGSTON, MFLE

MEMBER S CHOICE: THE REQUESTED SPANISH PHRASES FOR THE PHARMACY STEPHANIE LANGSTON, MFLE MEMBER S CHOICE: THE REQUESTED SPANISH PHRASES FOR THE PHARMACY STEPHANIE LANGSTON, MFLE MEMBER S CHOICE: THE REQUESTED SPANISH PHRASES FOR THE ACTIVITY DESCRIPTION Verification of identity, drug allergies

More information

ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO SGLT2 INHIBITORS PETER A. KRECKEL, R.PH.

ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO SGLT2 INHIBITORS PETER A. KRECKEL, R.PH. ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO SGLT2 INHIBITORS PETER A. KRECKEL, R.PH. ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO

More information

UNDERSTANDING AND TREATING ADHD TAMMIE LEE DEMLER, PHARMD, MBA, BCPP

UNDERSTANDING AND TREATING ADHD TAMMIE LEE DEMLER, PHARMD, MBA, BCPP UNDERSTANDING AND TREATING ADHD TAMMIE LEE DEMLER, PHARMD, MBA, BCPP UNDERSTANDING AND TREATING ADHD ACTIVITY DESCRIPTION Pharmacists can play a pro-active role in the treatment of ADHD. Management of

More information

ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D.

ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D. ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D. ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS ACTIVITY DESCRIPTION Antibiotic use in the safest

More information

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015 Exceptions to the Rule: A Pharmacy Law Presentation Eric Roath, Pharm.D. Director of Professional Practice Michigan Pharmacists Association Objectives 1. Identify basic legal frameworks that govern the

More information

What Every Practitioner Needs to Know About Controlled Substance Prescribing

What Every Practitioner Needs to Know About Controlled Substance Prescribing What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of

More information

How To Get A Prescription In Rhode Island

How To Get A Prescription In Rhode Island Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures

More information

Pharmacy Program Pre-Test

Pharmacy Program Pre-Test Last Name: Pharmacy Program Pre-Test * For each question, put a check mark for the one option that you think is correct. 1. A pharmacist receives a security prescription from a known local medical group

More information

REGULATION 3 PHARMACY TECHNICIANS

REGULATION 3 PHARMACY TECHNICIANS REGULATION 3 PHARMACY TECHNICIANS 03-00 PHARMACY TECHNICIANS REGISTRATION/PERMIT REQUIRED 03-00-0001 DEFINITIONS (a) Pharmacy technician means those individuals, exclusive of pharmacy interns, who assist

More information

Narcotic Treatment Programs

Narcotic Treatment Programs This is a copy of two small segments of the DEA Pharmacist Manual, April 2004. This material is absent from the DEA Practitioner s Manual. Narcotic Treatment Programs The Narcotic Addict Treatment Act

More information

UTCVM PHARMACY STANDARD OPERATING PROCEDURES

UTCVM PHARMACY STANDARD OPERATING PROCEDURES UTCVM PHARMACY STANDARD OPERATING PROCEDURES Updated: 4/5/2004 I. General Procedures A. Hours: The Pharmacy will be open Monday through Friday, 8:00AM to 6:00PM; Saturday 8:00AM to 1:00PM. The Pharmacy

More information

RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS

RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS RULES OF THE TENNESSEE BOARD OF NURSING R 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions

More information

Federal Regulations For Prescribing Scheduled Controlled Substances

Federal Regulations For Prescribing Scheduled Controlled Substances Federal Regulations For Prescribing Scheduled Controlled Substances HEIT TEMPLATE.PPT 1 Central Principle of Balance With the Use of Controlled Substances Dual imperative of government Establish a system

More information

Who is the DEA? New Narcotic Regulations and How They Affect Your Assisted Living Facility. 2009 DEA Audits. Scheduled/Controlled Drugs

Who is the DEA? New Narcotic Regulations and How They Affect Your Assisted Living Facility. 2009 DEA Audits. Scheduled/Controlled Drugs Who is the DEA? New Narcotic Regulations and How They Affect Your Assisted Living Facility Nancy Lamb RPh Good Day Pharmacy DEA- Drug Enforcement Administration This is not the State Health Department

More information

WellDyneRx Mail Service General Questions and Answers

WellDyneRx Mail Service General Questions and Answers WellDyneRx Mail Service General Questions and Answers I. Location/ Hours of Operation 1. Where is WellDyneRx Mail Pharmacy located? WellDyneRx mail pharmacy has two locations: 1) Centennial, CO, a suburb

More information

Topics in Pharmacy Technician and Intern Laws for Ohio Pharmacists

Topics in Pharmacy Technician and Intern Laws for Ohio Pharmacists Topics in Pharmacy Technician and Intern Laws for Ohio Pharmacists By: Donald L. Sullivan, R.Ph., Ph.D. Program Number: 036-367-10-001-H03 C.E.U.s: 0.1 Contact Hours: 1 hour Release Date: 02/23/2010 Expiration

More information

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS TABLE OF CONTENTS

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS TABLE OF CONTENTS CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS TABLE OF CONTENTS Section 1. Authority.... 1 Section 2. Definitions.... 1 Section 3. Qualifications and Requirements for Pharmacy Technicians and Pharmacy Technicians-in-Training....

More information

DISTRICT OF COLUMBIA MUNICIPAL REGULATIONS FOR PHARMACY TECHNICIANS

DISTRICT OF COLUMBIA MUNICIPAL REGULATIONS FOR PHARMACY TECHNICIANS Title 17 District of Columbia Municipal Regulations DISTRICT OF COLUMBIA MUNICIPAL REGULATIONS FOR PHARMACY TECHNICIANS Effective CHAPTER 99 PHARMACY TECHNICIANS Secs. 9900 General Provisions 9901 Term

More information

Date Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication

Date Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication POLICY SOMERSET COUNTY BOARD OF EDUCATION 1. PURPOSE Date Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication Number: 600-32 Date

More information

Controlled II Substance Rules & Regulations. Controlled II Substance Rules & Regulations

Controlled II Substance Rules & Regulations. Controlled II Substance Rules & Regulations North Carolina Board of Pharmacy Controlled Substance Pocketcard A brief summary of pertinent rules and regulations impacting the practice of pharmacy ~ Controlled II Substance Controlled II Substance

More information

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION CRIMINAL COMPLAINT

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION CRIMINAL COMPLAINT AO 91 (Rev. 11/11) Criminal Complaint AUSA Sarah Streicker (312) 353-1415 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION UNITED STATES OF AMERICA v. CASE NUMBER: UNDER SEAL

More information

Contents General Information... 1. General Information

Contents General Information... 1. General Information Contents General Information... 1 Preferred Drug List... 2 Pharmacies... 3 Prescriptions... 4 Generic and Preferred Drugs... 5 Express Scripts Website and Mobile App... 5 Specialty Medicines... 5 Prior

More information

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act.

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act. CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS Section 1. Authority. These regulations are promulgated as authorized by the Act. Section 2. Definitions. (a) "Pharmacy Technician-in-training" means an individual

More information

NH Laws / Rules Regarding Limited Retail Drug Distributors

NH Laws / Rules Regarding Limited Retail Drug Distributors NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant

More information

MUNICIPAL REGULATIONS for CLINICAL NURSE SPECIALISTS

MUNICIPAL REGULATIONS for CLINICAL NURSE SPECIALISTS MUNICIPAL REGULATIONS for CLINICAL NURSE SPECIALISTS CHAPTER 60 CLINICAL NURSE SPECIALIST Secs. 6000 Applicability 6001 General Requirements 6002 Term of Certificate 6003 Renewal of Certificate 6004 Educational

More information

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act.

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act. CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS Section 1. Authority. These regulations are promulgated as authorized by the Act. Section 2. Definitions. (a) "Pharmacy Technician-in-training" means an individual

More information

GENERAL INFORMATION. With Express Scripts, you have access to:

GENERAL INFORMATION. With Express Scripts, you have access to: CONTENTS GENERAL INFORMATION... 1 PREFERRED DRUG LIST....2 PHARMACIES... 3 PRESCRIPTIONS... 4 GENERIC AND PREFERRED DRUGS... 5 EXPRESS SCRIPTS WEBSITE AND MOBILE APP... 5 SPECIALTY MEDICATIONS... 6 PRIOR

More information

Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth

Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us

More information

DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY

DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY Remote Pharmacy Owner Name: DBA Name: Address: Telephone Number: Fax Number:

More information

MUNICIPAL REGULATIONS for NURSE PRACTITIONERS

MUNICIPAL REGULATIONS for NURSE PRACTITIONERS MUNICIPAL REGULATIONS for NURSE PRACTITIONERS CHAPTER 59 NURSE-PRACTITIONERS Secs. 5900 Applicability 5901 General Requirements 5902 Term of Certificate 5903 Renewal of Certificate 5904 Educational Requirements

More information

03 PHARMACY TECHNICIANS

03 PHARMACY TECHNICIANS 03 PHARMACY TECHNICIANS 03-00 PHARMACY TECHNICIANS REGISTRATION/PERMIT REQUIRED 03-00-0001 DEFINITIONS: A. PHARMACY TECHNICIAN: This term refers to those individuals identified as Pharmacist Assistants

More information

Agency # 070.00 REGULATION 9 PHARMACEUTICAL CARE/PATIENT COUNSELING

Agency # 070.00 REGULATION 9 PHARMACEUTICAL CARE/PATIENT COUNSELING Agency # 070.00 REGULATION 9 PHARMACEUTICAL CARE/PATIENT COUNSELING 09-00: PATIENT COUNSELING 09-00-0001--PATIENT INFORMATION, DRUG USE EVALUATION, AND PATIENT COUNSELING The intent of this regulation

More information

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016 FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: January 2016 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic

More information

ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS

ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS 610-X-5-.01 610-X-5-.02 610-X-5-.03 610-X-5-.04 610-X-5-.05 610-X-5-.06 610-X-5-.07

More information

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act.

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act. CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS Section 1. Authority. These regulations are promulgated as authorized by the Act. Section 2. Definitions. Direct supervision means that a licensed pharmacist

More information

SPRINGFIELD PUBLIC SCHOOLS COMPREHENSIVE SCHOOL HEALTH PROGRAM Administration of Medication in Springfield Public Schools

SPRINGFIELD PUBLIC SCHOOLS COMPREHENSIVE SCHOOL HEALTH PROGRAM Administration of Medication in Springfield Public Schools SPRINGFIELD PUBLIC SCHOOLS COMPREHENSIVE SCHOOL HEALTH PROGRAM Administration of Medication in Springfield Public Schools LAW: Massachusetts General Law, Chapter 94 C These medical guidelines are established

More information

Pharmacy Handbook. Understanding Your Prescription Benefit

Pharmacy Handbook. Understanding Your Prescription Benefit Pharmacy Handbook Understanding Your Prescription Benefit 1 Welcome to Your Prescription Drug Plan! Health Republic Insurance of New York has partnered with US Script to manage your prescription drug benefits.

More information

GEORGIA ~ STATUTE. Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq; 43-34-21 et seq (medical board provisions; PA committee)

GEORGIA ~ STATUTE. Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq; 43-34-21 et seq (medical board provisions; PA committee) GEORGIA ~ STATUTE STATUTE DATE Enacted 1972 REGULATORY BODY PA DEFINED SCOPE OF PRACTICE PRESCRIBING/DISPENSING SUPERVISION DEFINED Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq;

More information

MAPD-SNP Contract Numbers: H5852; H3132

MAPD-SNP Contract Numbers: H5852; H3132 Policy and Procedure No: 93608 PHP Transition Process Title: Part D Transition Process Department: Pharmacy Services, Managed Care Effective Date: 1/1/2006 Supercedes Policy No: PH 8.0 Reviewed/Revised

More information

Pharmacy Operating Guidelines & Information

Pharmacy Operating Guidelines & Information Pharmacy Operating Guidelines & Information RxAMERICA PHARMACY BENEFIT MANAGEMENT Pharmacy Operating Guidelines & Information Table of Contents I. Quick Reference List...3 C. D. E. Important Phone Numbers...

More information

247 CMR: BOARD OF REGISTRATION IN PHARMACY

247 CMR: BOARD OF REGISTRATION IN PHARMACY 247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,

More information

ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes

ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes # scored items 1. Regulations and Pharmacy Duties 35 A. Overview of technician

More information

- 1 - First Time Pharmacy Managers (Revised 02/02/2011)

- 1 - First Time Pharmacy Managers (Revised 02/02/2011) State of Connecticut Department of Consumer Protection Commission of Pharmacy 165 Capitol Avenue, Room 147 Hartford, CT 06106 - Telephone: 860-713-6070 ALL FIRST-TIME PHARMACY MANAGERS ARE REQUIRED TO

More information

SureScripts Frequently Asked Questions

SureScripts Frequently Asked Questions SureScripts Frequently Asked Questions What is the SureScripts Electronic Prescribing Network? The SureScripts Electronic Prescribing Network is the nation's largest and seeks to improve the prescribing

More information

NARCOTIC AND CONTROLLED DRUG MANAGEMENT

NARCOTIC AND CONTROLLED DRUG MANAGEMENT NARCOTIC AND CONTROLLED DRUG MANAGEMENT LHSC Policy available on the intranet at: http://appserver.lhsc.on.ca/policy/search_res.php? polid=pcc019&live=1 STAFF ADMINISTERING NARCOTICS: Manage area drug

More information

Welcome to OptumRx Your Prescription Benefit Program

Welcome to OptumRx Your Prescription Benefit Program Welcome to OptumRx Your Prescription Benefit Program OptumRx offers you more ways to improve your health, while keeping medications more affordable and accessible. Welcome to OptumRx OptumRx manages your

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Toll-Free Number Labeling and Related Requirements for Over-the-Counter and Prescription Drugs Marketed With Approved Applications Small Entity Compliance Guide U.S. Department of

More information

YOUR PRESCRIPTION DRUG PLAN BENEFIT OVERVIEW. Brought to you by Medco for The Motion Picture Industry Health Plan

YOUR PRESCRIPTION DRUG PLAN BENEFIT OVERVIEW. Brought to you by Medco for The Motion Picture Industry Health Plan YOUR PRESCRIPTION DRUG PLAN BENEFIT OVERVIEW Brought to you by Medco for The Motion Picture Industry Health Plan Your prescription drug benefit* You will make your co-payments according to the schedule

More information

11/26/2012. Implementation of Florida s PDMP. Disclosure

11/26/2012. Implementation of Florida s PDMP. Disclosure Implementation of Florida s PDMP Rebecca R. Poston Program Manager December 1, 2012 Disclosure I have no vested interest in or affiliation with any corporate organizations offering financial support or

More information

Patient access to medical records

Patient access to medical records New Law Alert No. 11 April 2002 California edition Patient access to medical records Acupuncture treatment modalities are expanded Cervical cancer screening CME required for pain management Mental health

More information

MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations

MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations Pri-Med Institute Marissa Seligman, PharmD [email protected] DISCLAIMER: For informational

More information

TRANSMUCOSAL IMMEDIATE RELEASE FENTANYL (TIRF) RISK EVALUATION AND MITIGATION STRATEGY (REMS)

TRANSMUCOSAL IMMEDIATE RELEASE FENTANYL (TIRF) RISK EVALUATION AND MITIGATION STRATEGY (REMS) Initial REMS approval: 12/2011 Most recent modification: /2014 TRANSMUCOSAL IMMEDIATE RELEASE FENTANYL (TIRF) RISK EVALUATION AND MITIGATION STRATEGY (REMS) Page 1 of 16 I. GOALS The goals of the TIRF

More information

CURES Prescription Drug Monitoring Program

CURES Prescription Drug Monitoring Program California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug

More information

Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS)

Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS) Initial REMS approval: 02/2013 Most recent modification: 06/2015 Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS) This REMS applies

More information

(1) Cancer drug means a prescription drug that is used to treat cancer or the side effects of cancer.

(1) Cancer drug means a prescription drug that is used to treat cancer or the side effects of cancer. DEPARTMENT OF PUBLIC HEALTH AND ENVIRONMENT Health Promotion and Disease Prevention Services CANCER DRUG REPOSITORY PROGRAM 6 CCR 1015-10 [Editor s Notes follow the text of the rules at the end of this

More information

Pharmacy 543 Pharmacy Laws & Ethics MIDTERM EXAMINATION October 27, 2008

Pharmacy 543 Pharmacy Laws & Ethics MIDTERM EXAMINATION October 27, 2008 Pharmacy 543 Pharmacy Laws & Ethics MIDTERM EXAMINATION October 27, 2008 Name: Last First Student Number Questions 1-30 are multiple choice. Please record your answers on Side 2 of a Standard Answer Sheet,

More information

(128th General Assembly) (Amended Substitute Senate Bill Number 89) AN ACT

(128th General Assembly) (Amended Substitute Senate Bill Number 89) AN ACT (128th General Assembly) (Amended Substitute Senate Bill Number 89) AN ACT To amend sections 4723.01, 4723.06, 4723.48, 4723.482, and 4723.50; to amend, for the purpose of adopting new section numbers

More information

Coventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company

Coventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company Coventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company PRESCRIPTION DRUG RIDER This Prescription Drug Rider is an attachment to the Coventry Health Care of Georgia, Inc. ( Health

More information

Developed by the Centers for Medicare & Medicaid Services

Developed by the Centers for Medicare & Medicaid Services Developed by the Centers for Medicare & Medicaid Services Every year millions of dollars are improperly spent because of fraud, waste, and abuse. It affects everyone. Including YOU. This training will

More information

Outpatient Prescription Drug Benefit

Outpatient Prescription Drug Benefit Outpatient Prescription Drug Benefit GENERAL INFORMATION This supplemental Evidence of Coverage and Disclosure Form is provided in addition to your Member Handbook and Health Plan Benefits and Coverage

More information

Delegation of Services Agreements Change in Regulations

Delegation of Services Agreements Change in Regulations Delegation of Services Agreements Change in Regulations Title 16, Division 13.8, Article 4, section 1399.540 was amended to include several requirements for the delegation of medical services to a physician

More information

MUNICIPAL REGULATIONS FOR NURSE- MIDWIVES

MUNICIPAL REGULATIONS FOR NURSE- MIDWIVES MUNICIPAL REGULATIONS FOR NURSE- MIDWIVES CHAPTER 58 NURSE-MIDWIVES Secs. 5800 Applicability 5801 General Requirement 5802 Term of Certificate 5803 Renewal of Certificate 5804 Educational and Experience

More information

Implementation of Florida s PDMP. Rebecca Poston Program Manager

Implementation of Florida s PDMP. Rebecca Poston Program Manager Implementation of Florida s PDMP Rebecca Poston Program Manager Disclaimer I have no relevant financial relationships or commercial interest in the content presented in this program. Learning Objectives:

More information

Drug and Alcohol Testing of Doctors. Medical Negligence Lawsuits. Initiative Statute.

Drug and Alcohol Testing of Doctors. Medical Negligence Lawsuits. Initiative Statute. Proposition 46 Drug and Alcohol Testing of Doctors. Medical Negligence Lawsuits. Initiative Statute. Yes/No Statement A YES vote on this measure means: The cap on medical malpractice damages for such things

More information

Guidelines for the use of DEA Registration number by House Staff

Guidelines for the use of DEA Registration number by House Staff Guidelines for the use of DEA Registration number by House Staff This document seeks to provide answers to a number of questions that have arisen within New York University School of Medicine/NYU Hospitals

More information

Health Professions Act BYLAWS SCHEDULE F. PART 3 Residential Care Facilities and Homes Standards of Practice. Table of Contents

Health Professions Act BYLAWS SCHEDULE F. PART 3 Residential Care Facilities and Homes Standards of Practice. Table of Contents Health Professions Act BYLAWS SCHEDULE F PART 3 Residential Care Facilities and Homes Standards of Practice Table of Contents 1. Application 2. Definitions 3. Supervision of Pharmacy Services in a Facility

More information

How do I work with my pharmacy management system vendor to enable my pharmacy for e-prescribing via the Surescripts network?

How do I work with my pharmacy management system vendor to enable my pharmacy for e-prescribing via the Surescripts network? Table of Contents How do I work with my pharmacy management system vendor to enable my pharmacy for e-prescribing via the Surescripts network?...1 Why should I report issues directly through my pharmacy

More information

OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program

OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program Full source: Wyoming Survey & Analysis Center (2013). Wyoming Prevention Needs Assessment: Interactive Graphing. Laramie, WY: University of Wyoming. (http://pnasurvey.org) Full Source: Wyoming Department

More information

New York City Office of Labor Relations Employee Benefits Program/Municipal Labor Committee

New York City Office of Labor Relations Employee Benefits Program/Municipal Labor Committee New York City Office of Labor Relations Employee Benefits Program/Municipal Labor Committee PICA PRESCRIPTION DRUG PROGRAM Self-Injectable Medications Chemotherapy Medications Questions & Answers Last

More information

2015 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan

2015 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan 2015 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan Plan Details, Programs, and Policies Table of Contents Click on the links below to be taken to that

More information